Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The MITRA-FR Trial vs the COAPT Trial: More Complementary Than Contradictory?

Luc JGY, Hong JC, Cheung AW, Cook RC, Skarsgard PL, Ye J, Nguyen TC.

Ann Thorac Surg. 2019 Jun 15. pii: S0003-4975(19)30841-0. doi: 10.1016/j.athoracsur.2019.04.083. [Epub ahead of print] No abstract available.

PMID:
31387795
2.

Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?

Senni M, Adamo M, Metra M, Alfieri O, Vahanian A.

Eur J Heart Fail. 2019 Jul;21(7):852-861. doi: 10.1002/ejhf.1491. Epub 2019 May 22. Review.

PMID:
31116485
3.

One more option in heart failure: correction of mitral regurgitation with MitraClip®.

Bini T, Agostini C, Stolcova M, Meucci F, Di Mario C.

Intern Emerg Med. 2019 Jul 11. doi: 10.1007/s11739-019-02140-1. [Epub ahead of print] Review.

PMID:
31297739
4.

MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results.

Pibarot P, Delgado V, Bax JJ.

Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):620-624. doi: 10.1093/ehjci/jez073.

5.

Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip.

Atianzar K, Zhang M, Newhart Z, Gafoor S.

Interv Cardiol. 2019 Feb;14(1):45-47. doi: 10.15420/icr.2018.40.1. Review.

6.

Futile MITRA-FR and a positive COAPT trial: Where does the evidence leave the clinicians?

Arora G, Patel N, Arora P.

Int J Cardiol Heart Vasc. 2018 Nov 19;22:18-19. doi: 10.1016/j.ijcha.2018.11.003. eCollection 2019 Mar. No abstract available.

7.

[The MITRA-FR and COAPT trials: the interventional cardiologist's point of view].

Masiero G, Musumeci G.

G Ital Cardiol (Rome). 2019 Apr;20(4):194-197. doi: 10.1714/3126.31071. Italian. No abstract available.

PMID:
30920545
8.

[The MITRA-FR and COAPT trials: the clinical cardiologist's point of view].

Senni M, Iacovoni A, Fiocca L.

G Ital Cardiol (Rome). 2019 Apr;20(4):190-193. doi: 10.1714/3126.31070. Italian. No abstract available.

PMID:
30920544
9.

32nd EACTS Annual Meeting clinical trials update: ART, IMPAG, MITRA-FR and COAPT.

Freemantle N, Milojevic M, Lim S, Fremes S, Pagano D.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):186-190. doi: 10.1093/ejcts/ezy396. No abstract available.

PMID:
30388217
10.

What do MITRA-FR and COAPT teach us about the percutaneous treatment of secondary mitral regurgitation?

Grinberg D, Donal E, Obadia JF.

EuroIntervention. 2019 Apr 20;14(17):1713-1715. doi: 10.4244/EIJV14I17A295. No abstract available.

11.

Lessons from MITRA-FR and COAPT studies: Can we hope for an indication for severe functional mitral regurgitation in systolic heart failure?

Juillière Y.

Arch Cardiovasc Dis. 2019 Jun - Jul;112(6-7):370-373. doi: 10.1016/j.acvd.2018.11.004. Epub 2018 Dec 31. No abstract available.

PMID:
30606473
12.

Transcatheter treatment of functional mitral regurgitation after MITRA-FR and COAPT - Patient selection is most important.

Orban M, Hausleiter J.

Int J Cardiol. 2019 Aug 1;288:57-58. doi: 10.1016/j.ijcard.2018.11.112. Epub 2018 Nov 24. No abstract available.

PMID:
30503191
13.

Percutaneous treatment of functional mitral regurgitation - Awaiting results of COAPT and MITRA-FR.

Orban M, Hausleiter J.

Int J Cardiol. 2018 Oct 15;269:89-90. doi: 10.1016/j.ijcard.2018.07.098. Epub 2018 Jul 21. No abstract available.

PMID:
30049488
14.

Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials.

Grayburn PA, Sannino A, Packer M.

JACC Cardiovasc Imaging. 2019 Feb;12(2):353-362. doi: 10.1016/j.jcmg.2018.11.006. Epub 2018 Dec 12. Review.

PMID:
30553663
15.

[Mitral clipping in the treatment of secondary mitral regurgitation].

Py A, Giannakopoulos G, Adamopoulos D, Rigamonti F, Iglesias JF, Meyer P, Müller H, Noble S.

Rev Med Suisse. 2019 May 22;15(652):1067-1071. French.

PMID:
31116521
16.

The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation.

Obadia JF, Armoiry X, Iung B, Lefèvre T, Mewton N, Messika-Zeitoun D, Cormier B, Berthiller J, Maucort-Boulch D, Boutitie F, Vaz B, Trochu JN, Vahanian A.

EuroIntervention. 2015 Mar;10(11):1354-60. doi: 10.4244/EIJV10I11A232.

17.

Secondary mitral regurgitation: percutaneous edge-to-edge repair on the cutting edge?

Kushneriuk D, Haddad H, Basran R, Shavadia JS.

Curr Opin Cardiol. 2019 Mar;34(2):185-193. doi: 10.1097/HCO.0000000000000593.

PMID:
30575648
18.

Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.

Arnold SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, Baron SJ, Kar S, Lim DS, Mishell JM, Abraham WT, Lindenfeld JA, Mack MJ, Stone GW, Cohen DJ; COAPT Investigators.

J Am Coll Cardiol. 2019 May 7;73(17):2123-2132. doi: 10.1016/j.jacc.2019.02.010. Epub 2019 Mar 17.

PMID:
30894288
19.

Error occurred: cannot get document summary

PMID:
31527746

20.

Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.

Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, Kapadia SR, McCarthy PM, Lim DS, Udelson JE, Zile MR, Gammie JS, Gillinov AM, Glower DD, Heimansohn DA, Suri RM, Ellis JT, Shu Y, Kar S, Weissman NJ, Stone GW.

Am Heart J. 2018 Nov;205:1-11. doi: 10.1016/j.ahj.2018.07.021. Epub 2018 Aug 1.

PMID:
30134187

Supplemental Content

Support Center